drugset / Trial / NCT00639756

The Effect of Allopurinol on Insulin Resistance and Blood Pressure

NCT00639756

Phase 2 Completed 60 enrolled Hospital Mateo Orfila
RandomizedParallel-groupOpen-labelPrevention

Summary

Studies in animals have found that allopurinol can markedly improve fructose induced metabolic syndrome. In this study we test the hypothesis that allopurinol may lower BP, reduce triglycerides, and improve metabolic parameters in subjects placed on a high fructose diet.

Timeline

Start
2008-06
Primary completion
2008-08
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Allopurinol Small molecule 300 mg

Indications